Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
7th grade Avg
|
|
New words:
ABMTR, academic, accessed, accessing, ACS, acute, adenocarcinoma, adjacent, Adjunct, adult, ALCL, allocated, alongside, anaplastic, Anna, ascertained, aseptic, aspect, assumption, augment, avidity, bed, biodistribution, Bioscience, breakdown, broad, Brown, BS, burden, carcinoma, carefully, carrier, cellular, CEO, chaired, chance, chelating, chemotherapeutic, Chicago, children, chimeric, clearance, College, Commonwealth, complementary, composed, Conjunction, consummate, convened, core, Corixa, Council, CR, curative, cytostatic, cytotoxic, cytoxic, deadly, departure, detected, Diamond, Dickey, diffuse, Digestive, discontinued, disproportionate, disseminated, dissociation, distinguished, distinguishing, DLCL, DNA, documentation, domain, DOTA, DOTMP, durable, DVM, EITF, Elliott, entity, Epidemiology, eradicate, Estate, Ewing, excellent, excretory, expert, Extraordinary, extremely, FASB, feature, Fellow, Fellowship, fermentation, fill, filling, Findlay, firm, Foerster, follicular, Foundation, France, Franchise, Freiberg, fully, fundamental, galactose, GD, Genentech, Germany, Ghalie, GlaxoSmithKline, goodwill, gradually, Grantee, Grayson, Habilitation, heavily, Herceptin, Heun, historical, Hodgkin, Ia, Immunex, impaired, impairment, indolent, induce, inefficiency, Infrequently, inserting, instrument, Intangible, intercompany, interfering, intracellular, irradiation, JD, journalBlood, Kidney, land, leadership, leaving, Lebanon, Legendi, Les, Leslie, leukemia, Lewak, Lilly, Linda, lymphocyte, Mainz, maximize, MBA, measured, MedImmune, member, Mercator, merged, met, methodology, Michigan, microangiopathy, microbial, migrate, mitigate, mode, Monsanto, Morrison, multidisciplinary, multiplying, Muzak, naked, Neile, neurology, nominal, Norwood, notable, NRX, Nuclear, occasion, onset, organizational, Orphan, Oster, outpatient, ovarian, owed, PACCAR, Pacific, palliative, panel, pathogen, payload, peer, penetrate, penetration, Pennsylvania, pharmacokinetic, Pierce, pipeline, PLC, Political, poor, poorly, power, preliminary, prelocalized, pretreated, prevalent, prime, prioritizing, Pritzker, processing, Progenitor, purification, purity, radioimmunotherapeutic, radiolabeled, radiolabeling, radioresponsive, radiosensitive, radiosensitivity, radiotherapeutic, readily, Real, recombinant, refractory, Registry, relief, renal, replication, resistant, Resource, responded, resume, resumption, reveal, revised, Rituxan, Rituximab, Roche, rounding, Royal, Sabo, sarcoma, saturating, Science, Searle, seldom, Selig, separate, separately, separation, shift, Simpler, skeleton, slowly, smaller, sophisticated, Southern, sparing, Specialty, SPHR, Stability, stably, strong, Sublicense, substance, sugar, synthesized, tail, tangible, Task, team, Thousand, TMA, Trastuzumab, trend, turn, Tyco, UK, undesirable, unmet, Untreated, Unusual, updating, uptake, USPTO, variability, variable, Venia, versatile, VII, Virginia, Wall, Wayne, wealth, Wharton, widespread, Wight, Wolfgang, written, XI, Zevalin
Removed:
agreed, attached, bacteria, began, bloodstream, bulky, bystander, cancelled, charge, clear, colon, combined, committed, constitute, decrease, Department, dislodge, display, engineered, faster, growing, hedge, hedging, hire, identical, imaging, improvement, Indemnification, indenture, inhibiting, injection, innocent, innovative, Interstate, intravenously, Janssen, Johnson, jurisdiction, kill, KPMG, letter, licensee, LLP, long, lung, lymph, manufactured, meaningful, metabolized, modest, moratorium, NV, observed, originate, paul, Pharmaceutica, preferentially, premium, Prepaid, principle, qualify, Radiology, reaching, reflecting, regression, reissue, relevant, remained, representative, repriced, requiring, resigning, restructured, restructuring, retired, return, safe, segregation, sensitive, sheet, Stanford, tendency, vitro, white, XXXXX, Yale
Filing tables
Filing exhibits
PARD similar filings
Filing view
External links
EXHIBIT 23
CONSENT OF INDEPENDENT
CERTIFIED PUBLIC ACCOUNTANTS
The Board of Directors
NeoRx Corporation:
We consent to incorporation by reference in the registration statements (Nos. 333-65862, 333-35442, 333-43712, and 333-45398) on Form S-3 and in the registration statements (Nos. 333-71368, 33-43860, 33-46317, 33-87108, 333-32583 and 333-41764) on Form S-8 of NeoRx Corporation, of our report dated January 25, 2002, relating to the consolidated balance sheets of NeoRx Corporation and subsidiary as of December 31, 2001 and 2000, and the related consolidated statements of operations, shareholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2001, which report appears in the December 31, 2001 annual report on Form 10-K of NeoRx Corporation.
/s/ KPMG LLP
Seattle, Washington
March 27, 2002